Patents for A61K 49 - Preparations for testing in vivo (35,376)
07/2014
07/29/2014US8792960 Magnetic resonance method and apparatus for automated analysis of joint inflammation, joint proteoglycan proportion, and joint osteoarthritis
07/29/2014US8791241 Fluorescent proteins with increased activity in cells
07/29/2014US8790872 Non-elispot assay
07/29/2014US8790660 Vaccine against Ehrlichia canis
07/29/2014US8790620 Radioactive diagnostic imaging agent
07/29/2014CA2621137C Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels
07/29/2014CA2411304C Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
07/25/2014DE202013011832U1 Färbemittel Dye
07/24/2014WO2014113167A1 Non-invasive imaging methods for patient selection for treatment with nanoparticulate therapeutic agents
07/24/2014WO2014037498A3 Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
07/24/2014US20140206992 Method for diagnosing cancer
07/24/2014US20140206837 Targeting vector-phospholipid conjugates
07/24/2014US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
07/24/2014US20140205657 Method of producing a cationic liposomal preparation comprising a lipophilic compound
07/24/2014US20140205545 Multivalent constructs for therapeutic and diagnostic applications
07/24/2014US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine
07/24/2014US20140205543 Method for diagnosing or treating tumors using sphingomyelin containing liposomes
07/24/2014US20140205541 Method for Detection of Characteristics of Organ Fibrosis
07/24/2014US20140205540 Method of Improving Balance
07/24/2014US20140205539 Dual Acting Prodrugs
07/24/2014US20140205538 Vaccines targeting cellular death receptors
07/24/2014DE102013001005A1 Verfahren für eine tumorselektive Röntgen-Computertomographie Method for a tumor-selective X-ray computed
07/23/2014EP2756459A1 Methods and compositions for objectively characterizing medical images
07/23/2014EP2755623A1 Smarttm solid oral dosage forms
07/23/2014CN103945875A 包含可注射生物材料水泥和射线不透性改善剂的组合物 Injectable biomaterial comprising cement and radiopacity improving agent composition
07/23/2014CN103945768A 谱学成像 Spectroscopic Imaging
07/23/2014CN103936985A 一种聚苯胺纳米粒子的制备方法及其应用 Method for preparing polyaniline nanoparticles and its application
07/23/2014CN103936859A 人源化l243抗体 Humanized antibody l243
07/23/2014CN103936830A 一种靶向肿瘤血管Anxa1标记前体NOTA-IF 7的制备方法 A tumor vessels Anxa1 labeling precursor NOTA-IF targeted preparation 7
07/23/2014CN103933585A 一种医用消毒超声耦合剂及其制备方法 A medical sterilization ultrasound coupling agent and preparation method
07/23/2014CN103933584A 一种叶酸修饰的超顺磁氧化铁纳米颗粒的制备方法 Preparation method of folic acid-modified superparamagnetic iron oxide nanoparticles
07/23/2014CN103933583A 抑制mgc-803细胞的手型金纳米团簇的制备及其用途 Preparation mgc-803 cells suppress hand-type gold clusters and their use
07/23/2014CN103932986A 一种制备胶体金标记的装载有pd药物的纳米脂质体的方法 Loading method for preparing a colloidal gold-labeled drug have pd nanoliposomes
07/23/2014CN103143040B 靶向β淀粉样蛋白显像剂的制备方法 Preparation of β-amyloid protein targeting imaging agent
07/23/2014CN103045606B K14-vegf转基因小鼠模型及其构建方法与应用 K14-vegf transgenic mouse model and its construction method and application
07/22/2014US8785391 Compound and method for treatment of alzheimer's disease and familial dementia
07/22/2014US8784846 Systems and methods for particle radiation enhanced delivery of therapy
07/22/2014US8784840 Method for screening modulators of apoptosis
07/22/2014US8784800 Method of delivering cell therapy to a target site
07/22/2014US8784778 MRI contrast agents endowed with concentration independent responsiveness
07/22/2014US8784777 Flexibly labeling peptides
07/22/2014US8784776 Use of FSH receptor ligands for diagnosis and therapy of cancer
07/22/2014US8784775 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
07/22/2014US8784774 Labeled molecular imaging agents and methods of use
07/22/2014US8784772 Urothelial differentiation of urothelial carcinoma: a bladder cancer stem cell model
07/22/2014CA2660572C Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof
07/22/2014CA2524883C Potassium-chloride cotransporter kcc2 modulation for treatment of pain
07/17/2014WO2014109927A1 Synthesis and isolation of dendrimer based imaging systems
07/17/2014US20140200450 Ultrasonic couplant spray
07/17/2014US20140199245 Oligonucleotide-based probes for detection of bacterial nucleases
07/17/2014US20140199243 Bifunctional phosphonate chelating agents
07/17/2014US20140199242 Compositions and methods for detection and treatment of cancer
07/17/2014US20140199241 Liposomes comprising polymer-conjugated lipids and related uses
07/17/2014US20140199235 Nanoparticle coated with ligand introduced with long hydrophobic chain and method for preparing same
07/16/2014EP2753929A1 Cellular uptake control systems
07/16/2014EP2753605A2 Compositions, methods, and systems for the synthesis and use of imaging agents
07/16/2014CN103930137A 卟啉-磷脂结合物微泡及其作为造影剂的用途 Porphyrin - phospholipid conjugate microbubbles and its use as a contrast agent
07/16/2014CN103930136A 新颖的含锰纳米结构 Novel nanostructured manganese
07/16/2014CN103930119A 顺势疗法的治疗方法及其组合物 Homeopathic treatments, and combinations thereof
07/16/2014CN103920168A 基于磁性纳米粒子检测三聚氰胺的核磁共振传感器及其制备方法和应用 NMR-based sensor and its preparation method and application of magnetic nanoparticles to detect melamine
07/16/2014CN103920167A MRI造影正增强多巴胺表面可控修饰的Gd<sub>2</sub>O<sub>3</sub>纳米粒子制备方法 MRI contrast enhancement of dopamine are controlled surface modification Gd <sub> 2 </ sub> O <sub> Preparation 3 </ sub> nanoparticle method
07/16/2014CN103920166A 一种新型乙型肝炎动物模型的建立方法与用途 Establish methods and uses a novel animal model of hepatitis B
07/16/2014CN103920165A 一种新型免疫性肝炎模型的建立方法及应用 Establishment and application of a new model of autoimmune hepatitis
07/16/2014CN103920155A 具有叶酸受体靶向和荧光双功能金簇的制备方法 Has prepared folate receptor targeting and fluorescent bifunctional gold clusters
07/16/2014CN103055329B 用于动脉粥样硬化易损斑块早期诊断的靶向磁性纳米探针的制备方法 Preparation targeted magnetic nanoparticles for atherosclerotic vulnerable plaque early diagnosis probe
07/16/2014CN102811748B 羟基化的磷酸化对比增强剂 Hydroxylated phosphorylation contrast enhancer
07/16/2014CN102796175B 血管活性肠肽1型受体的高亲和力结合多肽及其应用 Vasoactive intestinal peptide receptor type 1 high affinity binding polypeptides and Its Applications
07/16/2014CN102516398B 抗乳房炎转基因小鼠模型的构建方法及其专用载体 Construction Method anti-mastitis transgenic mouse model and its dedicated carrier
07/16/2014CN101678123B 包含疏水性化合物和聚氨基酸结合物的组合物 The composition comprising a hydrophobic compound and a polyamino acid conjugates
07/16/2014CN101123996B 用于增强成像对比度的组合物和方法 Contrast enhanced imaging compositions and methods for
07/15/2014US8778904 Methods and compositions for treating diseases, disorders or injury of the CNS
07/15/2014US8778390 Orally effective methylphenidate extended release powder and aqueous suspension product
07/15/2014US8778347 Fluorescent neutralization and adherence inhibition assays
07/15/2014US8778310 Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
07/15/2014US8778307 Targeted carriers for drug delivery across the gastrointestinal epithelium
07/15/2014US8778305 PSMA-binding agents and uses thereof
07/15/2014US8778304 TSPO-targeting compounds and uses thereof
07/15/2014US8778302 Procaspase 8-mediated disease targeting
07/15/2014US8778298 Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
07/10/2014WO2014107722A1 Manganese-based magnetic resonance contrast agents
07/10/2014WO2014107620A1 Method, apparatus and computer accessible medium for providing signal and contrast enhancement(s) in optical imaging methods
07/10/2014WO2014107419A1 Use of oscillating gradients of high magnetic field for specific destruction of cells labeled with magnetic nanoparticles
07/10/2014WO2014107379A1 Fluorination of aryl compounds
07/10/2014WO2014107055A1 Mri contrast agent including t1 contrast material coated on surface of nanoparticle support
07/10/2014WO2014106300A1 Pseudobezoar-based intraluminal gastrointestinal transplant
07/10/2014WO2014076602A3 Kit for diagnosing gluten sensitivity
07/10/2014US20140194741 Subcutaneous cavity marking device and method
07/10/2014US20140194733 Bismuth particle x-ray contrast agents
07/10/2014US20140193441 Method of Administering Porcine B-domainless fVIII
07/10/2014US20140193344 Imaging contrast agents and uses thereof
07/10/2014US20140193343 Measurement of body fluid volumes
07/10/2014US20140193342 Enzyme directed assembly of particle theranostics
07/10/2014US20140193341 Human induced neuronal cells
07/10/2014US20140193340 Luciferin Amides
07/10/2014US20140193339 New family of analogues and nadp+ or nadph, their preparation and their application in therapeutics
07/10/2014US20140193338 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
07/10/2014US20140193331 Multifunctional infrared-emitting composites
07/10/2014US20140193330 Compositions and methods for multimodal imaging
07/09/2014EP2750716A1 Novel manganese comprising nanostructures
07/09/2014EP2750600A1 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 354